Chae Mincheol, Cho Sukki, Chung Jin-Haeng, Yum Sungwon, Kim Kwhanmien, Jheon Sanghoon
Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine, Seoul, Korea.
J Chest Surg. 2022 Apr 5;55(2):101-107. doi: 10.5090/jcs.21.097.
Spread through air spaces (STAS) has recently emerged as a prognostic factor in lung adenocarcinoma, but little is known about the association of STAS and its grade with recurrence in neuroendocrine tumors (NETs). This study investigated the prognostic effect of STAS grade in NETs after curative resection.
Seventy-seven patients were retrospectively reviewed, including 9 with typical carcinoid (TC), 6 with atypical carcinoid (AC), 26 with large cell neuroendocrine carcinoma (LCNEC), and 36 with small cell carcinoma (SCC). STAS was defined as the presence of floating tumor cells within air spaces in the lung parenchyma beyond the edge of the main tumor. STAS was classified as grade 1 or 2 depending on whether it was found within or beyond one ×10 objective lens field away from the main tumor margin, respectively.
Fifty-four patients (70%) had STAS, including 22% with TC, 50% with AC, 69% with LCNEC, and 86% with SCC. Patients with STAS had more nodal metastasis, lymphatic and vascular invasion, tumor necrosis, and tumor subtypes other than TC. Among STAS cases, grade 2 STAS was present in 33% of AC, 78% of LCNEC, and 87% of SCC. The 5-year recurrence-free survival (RFS) rate was 81%, 63%, and 35% in patients with no STAS, grade 1, and grade 2 STAS, respectively. Multivariate analysis found that grade 2 STAS was an independent negative prognostic factor for RFS.
Although STAS itself was not associated with a poor prognosis, grade 2 STAS was an independent negative prognostic factor for RFS.
气腔播散(STAS)最近已成为肺腺癌的一个预后因素,但关于STAS及其分级与神经内分泌肿瘤(NETs)复发之间的关联知之甚少。本研究调查了STAS分级在NETs根治性切除术后的预后影响。
回顾性分析77例患者,其中包括9例典型类癌(TC)、6例非典型类癌(AC)、26例大细胞神经内分泌癌(LCNEC)和36例小细胞癌(SCC)。STAS定义为在主肿瘤边缘以外的肺实质气腔内存在漂浮的肿瘤细胞。根据其在距主肿瘤边缘一个×10物镜视野内或外被发现,STAS分为1级或2级。
54例患者(70%)存在STAS,其中TC患者中占22%,AC患者中占50%,LCNEC患者中占69%,SCC患者中占86%。有STAS的患者有更多的淋巴结转移、淋巴管和血管侵犯、肿瘤坏死以及除TC以外的肿瘤亚型。在有STAS的病例中,2级STAS在33%的AC、78%的LCNEC和87%的SCC中存在。无STAS、1级和2级STAS患者的5年无复发生存率(RFS)分别为81%、63%和35%。多因素分析发现2级STAS是RFS的独立负性预后因素。
虽然STAS本身与预后不良无关,但2级STAS是RFS的独立负性预后因素。